Carlisle Companies Incorporated · CSL · FY2026 Q2 · Calendar Q3 2026

Carlisle raises revenue outlook as costs temper margin expectations

Carlisle's Q2 showed resilient reroofing demand, pricing, and operational improvements supporting growth despite raw-material and freight inflation. The raised revenue outlook is constructive, but flat margin guidance keeps cost recovery and execution central to the outlook.

Reported After market closeNYSEBasic Materials $14.94B market cap
100quality score

Earnings scorecard

Reported versus consensus
Reported EPS $7.03 Consensus $6.35
EPS surprise +10.7% Reported versus consensus
Reported revenue $1.57B Consensus $1.48B
Revenue surprise +6.4% Reported versus consensus

Market reaction

event-close to next-session close
Stock move +10.6% Event window
SPY move +1.7% Same window
Abnormal move +8.9% Stock minus SPY
Volume 1.3× Versus trailing sessions
Subsequent drift -2.5% Up to 20 sessions
CSLSPY benchmark

Ask FN2 about CSL FY2026 Q2

Transcript, numbers and history already loaded

Free account. Your question opens in FN2 with this report's transcript and numbers attached.

Transcript intelligence

What changed

Management reported record Q2 revenue and EPS, raised the full-year revenue outlook to mid-single-digit growth, and moved EBITDA margin guidance to flat. Pricing actions are expected to turn positive in the second half of 2026, while automation and in-house resin capacity supported CWT margin expansion.

Guidance delta

Full-year revenue guidance was raised to mid-single-digit growth; EBITDA margin guidance moved to flat.

Key takeaways

  • Record Q2 revenue and EPS were achieved despite raw-material and freight pressures.
  • Pricing actions, freight surcharges, and operating efficiencies supported the quarter.
  • Reroofing demand remained a structural growth driver, while new-construction markets were softer.
  • The higher revenue outlook is offset by flat margin guidance as cost recovery continues.
  • Strong cash generation supports planned buybacks, dividend growth, and continued investment.

Management priorities

  • Roll out approximately a dozen new products in 2026.
  • Expand automation, footprint consolidation, and in-house resin capacity.
  • Pursue accretive M&A meeting Carlisle's strategic criteria.
  • Use the Carlisle Operating System and AI tools to improve efficiency.
  • Continue investment in innovation alongside shareholder returns.

Follow CSL with an agent that reads every filing, transcript, and price print. Free to start.

Try FN2 free

Earnings History

Estimate Beat Miss Match
CSL EPS earnings history estimate and actual scatter chart 10 reported fiscal quarters and 4 future estimate-only quarters. Q2 '24 estimate $5.99 Q2 '24 actual $6.24, beat Q3 '24 estimate $5.82 Q3 '24 actual $5.78, miss Q2 '25 estimate $6.58 Q2 '25 actual $6.27, miss Q3 '25 estimate $5.47 Q3 '25 actual $5.61, beat Q4 '25 estimate $3.58 Q4 '25 actual $3.90, beat Q1 '26 estimate $3.33 Q1 '26 actual $3.63, beat Q2 '26 estimate $6.35 Q2 '26 actual $7.03, beat Q3 '26 estimate $5.89 Q3 '26 actual $5.92, beat Q4 '26 estimate $4.46 Q1 '27 estimate $4.15 Q2 '27 estimate $8.17 Q3 '27 estimate $6.87
Show 2 more >

Analyst Consensus ?

ConsensusBuy25 ratings
Bullish1664.0%
Neutral936.0%
Bearish00.0%

Analyst 52W Price Targets

$376.31Current
$355Low
$419.55Average
$480High

Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 31, 2026. Not an FN2 forecast.

Firm-level rating actions

FMP grade actions identify the grading firm, not a named analyst.

FirmRatingPrior ratingActionDate
Baird Outperform OutperformMaintainOct 13, 2026
Truist Securities Hold HoldMaintainJul 7, 2026
Oppenheimer Outperform OutperformMaintainApr 24, 2026
JP Morgan Overweight OverweightMaintainMar 9, 2026
Goldman Sachs Buy BuyMaintainOct 13, 2025
Loop Capital Hold BuyDowngradeJul 31, 2025
Zelman & Assoc Neutral UnderperformUpgradeApr 14, 2025
Jefferies Hold BuyDowngradeSep 26, 2023
BMO Capital Outperform OutperformMaintainMay 1, 2023
Credit Suisse Outperform OutperformMaintainApr 11, 2023
Zelman Buy BuyMaintainNov 15, 2021
Northcoast Research Buy NeutralUpgradeJun 30, 2021
Longbow Research Neutral BuyDowngradeApr 12, 2021
Berenberg Buy BuyMaintainJan 14, 2020
Buckingham Research Neutral BuyDowngradeJul 8, 2019
B. Riley Securities Buy BuyMaintainOct 24, 2018
B. Riley FBR Buy BuyMaintainOct 24, 2018
Buckingham Buy BuyMaintainSep 5, 2017
Topeka Buy BuyMaintainMay 26, 2016
Wunderlich Buy BuyMaintainDec 16, 2015
KeyBanc Equal Weight Sector WeightMaintainSep 29, 2015
RBC Capital Perform Sector PerformMaintainNov 25, 2014
FBR Capital Outperform Market PerformUpgradeApr 15, 2014
SunTrust Robinson Humphrey Buy NeutralUpgradeJul 24, 2013
Citigroup Neutral NeutralMaintainApr 25, 2013
Show less

Named analyst price targets

Upside is calculated against the persisted current price $376.31. FMP does not supply a rating on these named-analyst rows.

FirmAnalyst52W targetPrice when postedUpsideDate
Robert W. BairdAnalyst unavailable$410$345.55 +9.0%Oct 29, 2026
D.A. DavidsonGarik Shmois$355$321.74 -5.7%Oct 9, 2026
D.A. DavidsonAnalyst unavailable$410$362.52 +9.0%Aug 24, 2026
Robert W. BairdAnalyst unavailable$412$334.54 +9.5%Jul 30, 2026
Robert W. BairdAnalyst unavailable$405$345.39 +7.6%Jul 20, 2026
Raymond JamesSam Darkatsh$425$361.28 +12.9%Apr 27, 2026
Truist FinancialKeith Hughes$360$368.57 -4.3%Apr 24, 2026
OppenheimerAnalyst unavailable$425$363.7 +12.9%Apr 24, 2026
Robert W. BairdTimothy Wojs$425$363.7 +12.9%Apr 24, 2026
Robert W. BairdAnalyst unavailable$402$357.71 +6.8%Apr 15, 2026
Robert W. BairdAnalyst unavailable$420$355.84 +11.6%Feb 4, 2026
Truist FinancialKeith Hughes$340$330 -9.6%Oct 30, 2025
Robert W. BairdAnalyst unavailable$385$323.92 +2.3%Oct 13, 2025
Truist FinancialKeith Hughes$350$338.01 -7.0%Sep 22, 2025
Loop Capital MarketsAnalyst unavailable$395$410.57 +5.0%Jul 31, 2025
Truist FinancialKeith Hughes$390$373.01 +3.6%Apr 24, 2025
Robert W. BairdTimothy Wojs$506$480.93 +34.5%Oct 15, 2024
Loop Capital MarketsGarik Shmois$475$420.3 +26.2%Sep 18, 2024
OppenheimerBryan Blair$480$401.71 +27.6%Sep 4, 2024
Robert W. BairdTimothy Wojs$500$430.54 +32.9%Jul 15, 2024
Robert W. BairdTimothy Wojs$435$400.5 +15.6%Apr 9, 2024
Goldman SachsSusan Maklari$455$391.19 +20.9%Apr 3, 2024
Robert W. BairdTimothy Wojs$300$245.33 -20.3%Apr 18, 2022
Show less

Track every rating change on CSL the moment it posts. Free to start.

Start free

Company context

Snapshot as of publication

Carlisle Companies Incorporated operates as a manufacturer and supplier of building envelope products and solutions in the United States, Europe, North America, and internationally. It operates through two segments, Carlisle Construction Materials (CCM) and Carlisle Weatherproofing Technologies (CWT). The CCM segment offers single-ply roofing solutions, including ethylene propylene diene monomer, thermoplastic polyolefin, polyvinyl chloride membrane, polyiso insulation, and engineered metal roofing and wall panel systems for commercial and residential buildings.…

Historical context

All CSL earnings

Basic Materials peers this season

Latest reports in the same sector

Latest beats and misses

Who reports next

Get the CSL recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.

Sources

  1. Earnings call transcript and parsed analysis · 2026-07-30T03:08:49.382695+00:00
  2. FN2 earnings calendar · 2026-09-03T01:23:14.877038+00:00
  3. Polygon adjusted daily market bars · 2026-10-31T14:40:41.767133+00:00
  4. Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-31T14:40:41.764268+00:00

Methodology

Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.

Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.

Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.

By FN2 Research · Updated · As of 2026-10-31. For educational purposes only; not investment advice.